Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2510577 | Antiviral Research | 2011 | 4 Pages |
Abstract
Enhanced sensitivity Trofile® (ES-Trofile®) is the most frequently used technique to assay HIV tropism. A clinical approach to predict CCR5-antagonists efficacy, based on the virological response to a short-term maraviroc exposure (Maraviroc Clinical Test, MCT), has been recently reported. We compared the results of ES-Trofile® with MCT in 47 HIV-infected patients, and a global discordance around 15% was observed between the phenotypic method and the clinical approach. Discordance results were mainly found in patients with an ES-Trofile® reported as dual/mixed. These provocative results might have important clinical implications and should be considered in order to accurately prescribe treatment with CCR5 antagonists.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Miguel Genebat, Ezequiel Ruiz-Mateos, Alejandro González-Serna, Ildefonso Pulido, Mª Ángeles Muñoz-Fernández, Sara Ferrando-Martínez, Manuel Leal,